MDS, a Canadian provider of products and services to the global life sciences markets, has served Atomic Energy of Canada Limited with notice of arbitration proceedings. MDS will be seeking an order to compel AECL to fulfil its contractual obligations under its 2006 interim and long-term supply agreement and, if not granted, will ask for significant monetary damages. The company has concurrently filed a court claim for C$1.6 billion ($1.57 billion) in damages against AECL, for negligence and breach of contract, and against the government of Canada, for inducing breach of contract and for interference with economic relations.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze